Â鶹ŮÓÅ

Jessie Quinn of Sacramento was 36 years old when loss of appetite, weight loss, some eye issues and finally pelvic pain sent her to the emergency room in 2010. Tests quickly revealed she had acute myeloid leukemia — a type of blood cancer that progresses quickly — and doctors told her that chemotherapy would probably not be enough; she would need a bone-marrow transplant. Quinn, who has a science background, knew that finding a donor would be difficult. In college, she had donated to a bone-marrow registry after learning that people like her, with a mixed racial heritage, have a much harder time than others finding a match. (Berger, 9/5)

A cancer diagnosis doesn’t automatically lead to an overhaul of unhealthy habits, says a study in the Journal of Cancer Survivorship. People who had survived various cancers had similar rates of physical inactivity, unhealthy eating habits and other risky health behaviors as people not diagnosed with cancer, the study found. Some habits, such as smoking, were more prevalent among survivors, particularly women. (Lukits, 9/5)

A new class of drugs could be a significant step forward in the treatment of ovarian cancer, one of the most lethal forms of the disease. The drugs, known as PARP inhibitors, are thought to help the body slow the disease’s progression by helping to prevent cancer cells from repairing themselves after chemotherapy treatment, thereby shrinking tumors and delaying relapses. (Walker, 9/5)